drugset / Trial / NCT07417124
Assess the Safety and Tolerability of SNS851 in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase I, randomized, double-blind study designed to evaluate the safety, tolerability and pharmacokinetics of subcutaneous administration of SNS851 in healthy participants.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SNS851 | Small interfering RNA (siRNA) | — | Subcutaneous |